Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy

NCT00728520 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

FED

Sponsor class

Conditions

Acute Myeloid Leukemia
Elderly

Interventions

DRUG: Azacitidine

Sponsor

Kansas City Veteran Affairs Medical Center